- Home
- IBG vs ADIL Comparison
IBG vs ADIL Comparison
Compare IBG & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IBG | ADIL |
|---|---|---|
| Founded | 2018 | 2010 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8M | 7.8M |
| IPO Year | 2024 | 2018 |
Fundamental Metrics
Financial Performance| Metric | IBG | ADIL |
|---|---|---|
| Price | $2.35 | $0.29 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 262.0K | ★ 344.9K |
| Earning Date | 05-12-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,931,243.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.48 | $0.22 |
| 52 Week High | $9.85 | $1.30 |
Technical Indicators
Market Signals| Indicator | IBG | ADIL |
|---|---|---|
| Relative Strength Index (RSI) | 47.33 | 39.05 |
| Support Level | $2.36 | $0.30 |
| Resistance Level | $2.75 | $0.32 |
| Average True Range (ATR) | 0.34 | 0.02 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 38.17 | 23.20 |
Price Performance
Historical ComparisonAbout IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.